pubmed-article:19239365 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C0242356 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C1519941 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:19239365 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
pubmed-article:19239365 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:19239365 | pubmed:dateCreated | 2009-3-11 | lld:pubmed |
pubmed-article:19239365 | pubmed:abstractText | Expert-based genotypic interpretation systems are standard methods for guiding treatment selection for patients infected with human immunodeficiency virus type 1. We previously introduced the software pipeline geno2pheno-THEO (g2p-THEO), which on the basis of viral sequence predicts the response to treatment with a combination of antiretroviral compounds by applying methods from statistical learning and the estimated potential of the virus to escape from drug pressure. | lld:pubmed |
pubmed-article:19239365 | pubmed:language | eng | lld:pubmed |
pubmed-article:19239365 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19239365 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19239365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19239365 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19239365 | pubmed:month | Apr | lld:pubmed |
pubmed-article:19239365 | pubmed:issn | 0022-1899 | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:ZazziMaurizio... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:FesselW... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:ShaferRobert... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:KaiserRolfR | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:SönnerborgAnd... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:BeerenwinkelN... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:LengauerThoma... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:RheeSoo-YonSY | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:DäumerMartinM | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:BüchJoachimJ | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:SchülterEugen... | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:PeresYardenaY | lld:pubmed |
pubmed-article:19239365 | pubmed:author | pubmed-author:AltmannAndréA | lld:pubmed |
pubmed-article:19239365 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19239365 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19239365 | pubmed:volume | 199 | lld:pubmed |
pubmed-article:19239365 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19239365 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19239365 | pubmed:pagination | 999-1006 | lld:pubmed |
pubmed-article:19239365 | pubmed:dateRevised | 2009-6-8 | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:meshHeading | pubmed-meshheading:19239365... | lld:pubmed |
pubmed-article:19239365 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19239365 | pubmed:articleTitle | Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database. | lld:pubmed |
pubmed-article:19239365 | pubmed:affiliation | Max Planck Institute for Informatics, Saarbrücken, University of Cologne, Cologne, Germany. altmann@mpi-inf.mpg.de | lld:pubmed |
pubmed-article:19239365 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19239365 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19239365 | pubmed:publicationType | Validation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19239365 | lld:pubmed |